RFK Jr. Removes All Members of CDC Vaccine Advisory Panel
The Department of Health and Human Services is dismissing all 17 members that make up one of the main committees advising the US government on vaccine safety and policy, an unprecedented move to reshape a key scientific panel. 'A clean sweep is needed to reestablish public confidence in vaccine science,' Health Secretary Robert F. Kennedy Jr. said Monday in an opinion piece published in the Wall Street Journal. The group, known as the Advisory Committee on Immunization Practices, or ACIP, reviews the latest data and makes recommendations to the Centers for Disease Control and Prevention, which typically implements them. The group's recommendations are influential and determine whether insurers cover shots, among other things. (Source: Bloomberg)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Health Line
37 minutes ago
- Health Line
Is There an Azstarys Shortage?
Azstarys is a prescription drug used to treat ADHD. Some ADHD medications have recently been in short supply. Learn whether Azstarys is affected and how to check its availability. Azstarys is not currently listed in the Food and Drug Administration (FDA) drug shortages database. Here's what to know about why some ADHD medications may be hard to find and how to check for drug shortages. Is there a shortage of other ADHD drugs? In recent years, several ADHD medications have been in short supply. A few examples include Adderall, Concerta, Ritalin, and Vyvanse. It's not yet clear when these shortages will fully resolve. These shortages have affected both brand-name and generic versions of the drugs. As a result, some people have worked with their doctor to switch to a different medication or adjust their ADHD treatment plan. To check the current status of Aztarys and other ADHD medications, visit the FDA drug shortages website. How do ADHD drug shortages affect people? Shortages of ADHD medications can make it harder for people to stick with their treatment plan. This can cause ADHD symptoms to return or become more difficult to manage. A lack of consistent access to ADHD medication may also increase stress and affect mental health. Other possible effects of disrupted access to ADHD medication include: difficulty focusing or completing daily tasks increased impulsivity or emotional outbursts difficulty falling or staying asleep withdrawing from social, family, or work activities If you're having trouble filling a prescription for an ADHD medication, talk with your doctor or pharmacist. They may recommend alternatives or adjust your treatment plan based on what's available. What causes a drug shortage? Several factors can lead to a medication being in short supply. Common causes of ADHD drug shortages include: Increased demand: More people receiving diagnoses of ADHD have led to greater demand for medications. This can strain manufacturers and reduce availability at pharmacies. Regulatory limits: Stimulant medications used to treat ADHD, including Azstarys, are controlled substances. The Drug Enforcement Administration (DEA) sets yearly production limits for these medications. If demand rises suddenly, these limits may contribute to shortages. Supply chain issues: Shortages of raw materials, packaging supplies, or labor can delay the manufacturing and availability of ADHD drugs. When multiple ADHD medications are in short supply at the same time, it can be especially hard for pharmacies to keep any option in stock. Even when generic forms are available, they may be affected by the same issues as brand-name drugs. As a result, generics may be just as difficult to find during a shortage. How can I check whether Azstarys is available near me? Azstarys is not currently listed by the FDA as being in shortage. However, some people may still experience delays when trying to fill their prescription. Availability can vary depending on your pharmacy, location, and insurance plan. If you're having trouble finding Azstarys, start by talking with a pharmacist. If possible, visit the pharmacy in person. Some pharmacies may not share inventory details for ADHD medications over the phone. You can also check pharmacy websites or apps, which sometimes offer tools to look up availability online. Keep in mind that availability may change as new shipments arrive. You can also check with your insurance provider. If Azstarys isn't available through your plan's preferred pharmacy, your insurer may be able to help you locate another pharmacy. In some cases, you may want to reach out to the drug manufacturer for information about availability in your area. To learn more about contacting the manufacturer, visit the Azstarys website.
Fox News
an hour ago
- Fox News
RFK Jr scraps vaccine committee members in effort to restore 'public trust'
The Department of Health and Human Services dismissed all the members of the Advisory Committee on Immunization Practices (ACIP) on Monday. The committee's job was to decide and "make recommendations" related to the necessity and use of vaccines, according to an HHS news release. All the current members of the committee were brought in under the Biden administration, and 13 of them were put on the committee last year. HHS said it would take until 2028 for most of the members to be replaced if they served their full term. Public debate about vaccines, especially whether government or workplaces should mandate them, escalated during the COVID-19 pandemic. Much of the criticism and skepticism fell on the Centers for Disease Control and Prevention, which ACIP advises. "Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," Secretary Robert F. Kennedy said in a statement on Monday. "The public must know that unbiased science—evaluated through a transparent process and insulated from conflicts of interest—guides the recommendations of our health agencies." The HHS release noted that the next meeting for the committee will be June 25-27 in Atlanta, and the committee will have new people that are "currently under consideration." "A clean sweep is necessary to reestablish public confidence in vaccine science," Kennedy continued. "ACIP's new members will prioritize public health and evidence-based medicine. The Committee will no longer function as a rubber stamp for industry profit-taking agendas. The entire world once looked to American health regulators for guidance, inspiration, scientific impartiality, and unimpeachable integrity. Public trust has eroded. Only through radical transparency and gold standard science, will we earn it back." HHS cited an executive order from President Donald Trump saying that changes were needed in how the federal government plays a role in science and health. "Unfortunately, the Federal Government has contributed to this loss of trust. In several notable cases, executive departments and agencies (agencies) have used or promoted scientific information in a highly misleading manner," the order stated. "For example, under the prior Administration, the Centers for Disease Control and Prevention issued COVID-19 guidance on reopening schools that incorporated edits by the American Federation of Teachers and was understood to discourage in-person learning," the order, signed on May 23, continued. "This guidance's restrictive and burdensome reopening conditions led many schools to remain at least partially closed, resulting in substantial negative effects on educational outcomes — even though the best available scientific evidence showed that children were unlikely to transmit or suffer serious illness or death from the virus, and that opening schools with reasonable mitigation measures would have only minor effects on transmission," it added. Kennedy was confirmed by the Senate to lead the department in February after Trump nominated him.
Yahoo
an hour ago
- Yahoo
US health secretary dismisses entire vaccine advisory panel
US Health Secretary Robert F. Kennedy Jr. on Monday announced he was dismissing all members of a key federal vaccine advisory panel, accusing its members of conflicts of interest -- his latest salvo against the nation's immunization policies. The decision to remove all 17 experts of the Advisory Committee on Immunization Practices (ACIP) was unveiled in a Wall Street Journal op-ed and an official press release. Kennedy cast the overhaul as essential to rebuilding public trust, accusing the panel of being compromised by financial ties to pharmaceutical companies. "Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," he said in the statement from the Department of Health and Human Services. "The public must know that unbiased science -- evaluated through a transparent process and insulated from conflicts of interest -- guides the recommendations of our health agencies." In his op-ed, Kennedy claimed the panel had been "plagued with persistent conflicts of interest" and had become "little more than a rubber stamp for any vaccine." He said new members were being considered to replace the outgoing experts, who had been appointed for their recognized expertise and were required to submit conflict-of-interest disclosures. Kennedy has spent the past two decades promoting vaccine misinformation, including the widely debunked claim that the measles, mumps and rubella (MMR) shot causes autism. Since taking office, he has curtailed access to Covid-19 vaccines and continued to sow doubts about the MMR shot -- even as the United States experiences its worst measles outbreak in years, with three reported deaths and more than 1,100 cases. Experts warn the number of official cases may vastly understate the true toll of the measles outbreak. ia/aha
